Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Pulmonology
•
Critical Care
•
ARDS
Do you use spO2 to define ARDS in patients with darker skin pigmentation?
Related Questions
Do you perform PEEP titration while patients are proned?
Do you consider use of convalescent plasma early in disease course in COVID-19 induced ARDS in mechanically ventilated patients?
Do you continue to prone patients with severe ARDS after initiation of VV-ECMO?
How do you manage concurrent nonlife-threatening hemoptysis and acute pulmonary embolism?
What factors do you consider for patients on an individual basis when establishing a post-cardiac arrest MAP goal after ROSC is achieved, considering some may benefit from higher MAP goals for optimal cerebral perfusion?
Does the use of NIV for pre-oxygenation delay the time to intubation?
Do you choose an antibiotic with CSF penetration, such as nafcillin over cefazolin, in the setting of MSSA endocarditis with septic emboli to the brain (assuming no concomitant meningitis or brain abscess)?
What is your hemoglobin target for PRBC transfusion in cases of acute brain injury?
What would be your second pressor of choice if patients with LVOT obstruction remain persistently hypotensive on phenylephrine?
Do you transcutaneously pace or cardiovert patients with DNR status who have not lost pulses?
